The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Opioid Use Disorder Treatment Market Research Report 2025

Global Opioid Use Disorder Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1937225

No of Pages : 89

Ask Your Query
Synopsis
The global Opioid Use Disorder Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Opioid Use Disorder Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Opioid Use Disorder Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Opioid Use Disorder Treatment include Trevena, Aphios, Kyowa kirin, Gamida-Cell, Novartis, Titan Pharmaceutical, Hikma Pharmaceutical, MediciNova and Alkermes, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Opioid Use Disorder Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Use Disorder Treatment.
Report Scope
The Opioid Use Disorder Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Opioid Use Disorder Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Opioid Use Disorder Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Trevena
Aphios
Kyowa kirin
Gamida-Cell
Novartis
Titan Pharmaceutical
Hikma Pharmaceutical
MediciNova
Alkermes
BioDelivery Sciences International
Segment by Type
Romiplostim
Omidubicel
Nalmefene
Others
Segment by Application
Hospital
Drug Stores
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioid Use Disorder Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioid Use Disorder Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Opioid Use Disorder Treatment Market Overview
1.1 Product Overview and Scope of Opioid Use Disorder Treatment
1.2 Opioid Use Disorder Treatment Segment by Type
1.2.1 Global Opioid Use Disorder Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Romiplostim
1.2.3 Omidubicel
1.2.4 Nalmefene
1.2.5 Others
1.3 Opioid Use Disorder Treatment Segment by Application
1.3.1 Global Opioid Use Disorder Treatment Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Other
1.4 Global Opioid Use Disorder Treatment Market Size Estimates and Forecasts
1.4.1 Global Opioid Use Disorder Treatment Revenue 2019-2030
1.4.2 Global Opioid Use Disorder Treatment Sales 2019-2030
1.4.3 Global Opioid Use Disorder Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Opioid Use Disorder Treatment Market Competition by Manufacturers
2.1 Global Opioid Use Disorder Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Opioid Use Disorder Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Opioid Use Disorder Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Opioid Use Disorder Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Opioid Use Disorder Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Opioid Use Disorder Treatment, Product Type & Application
2.7 Opioid Use Disorder Treatment Market Competitive Situation and Trends
2.7.1 Opioid Use Disorder Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Opioid Use Disorder Treatment Players Market Share by Revenue
2.7.3 Global Opioid Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Opioid Use Disorder Treatment Retrospective Market Scenario by Region
3.1 Global Opioid Use Disorder Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Opioid Use Disorder Treatment Global Opioid Use Disorder Treatment Sales by Region: 2019-2030
3.2.1 Global Opioid Use Disorder Treatment Sales by Region: 2019-2024
3.2.2 Global Opioid Use Disorder Treatment Sales by Region: 2025-2030
3.3 Global Opioid Use Disorder Treatment Global Opioid Use Disorder Treatment Revenue by Region: 2019-2030
3.3.1 Global Opioid Use Disorder Treatment Revenue by Region: 2019-2024
3.3.2 Global Opioid Use Disorder Treatment Revenue by Region: 2025-2030
3.4 North America Opioid Use Disorder Treatment Market Facts & Figures by Country
3.4.1 North America Opioid Use Disorder Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Opioid Use Disorder Treatment Sales by Country (2019-2030)
3.4.3 North America Opioid Use Disorder Treatment Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Opioid Use Disorder Treatment Market Facts & Figures by Country
3.5.1 Europe Opioid Use Disorder Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Opioid Use Disorder Treatment Sales by Country (2019-2030)
3.5.3 Europe Opioid Use Disorder Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Opioid Use Disorder Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Opioid Use Disorder Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Opioid Use Disorder Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Opioid Use Disorder Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Opioid Use Disorder Treatment Market Facts & Figures by Country
3.7.1 Latin America Opioid Use Disorder Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Opioid Use Disorder Treatment Sales by Country (2019-2030)
3.7.3 Latin America Opioid Use Disorder Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Opioid Use Disorder Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Opioid Use Disorder Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Opioid Use Disorder Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Opioid Use Disorder Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Opioid Use Disorder Treatment Sales by Type (2019-2030)
4.1.1 Global Opioid Use Disorder Treatment Sales by Type (2019-2024)
4.1.2 Global Opioid Use Disorder Treatment Sales by Type (2025-2030)
4.1.3 Global Opioid Use Disorder Treatment Sales Market Share by Type (2019-2030)
4.2 Global Opioid Use Disorder Treatment Revenue by Type (2019-2030)
4.2.1 Global Opioid Use Disorder Treatment Revenue by Type (2019-2024)
4.2.2 Global Opioid Use Disorder Treatment Revenue by Type (2025-2030)
4.2.3 Global Opioid Use Disorder Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Opioid Use Disorder Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Opioid Use Disorder Treatment Sales by Application (2019-2030)
5.1.1 Global Opioid Use Disorder Treatment Sales by Application (2019-2024)
5.1.2 Global Opioid Use Disorder Treatment Sales by Application (2025-2030)
5.1.3 Global Opioid Use Disorder Treatment Sales Market Share by Application (2019-2030)
5.2 Global Opioid Use Disorder Treatment Revenue by Application (2019-2030)
5.2.1 Global Opioid Use Disorder Treatment Revenue by Application (2019-2024)
5.2.2 Global Opioid Use Disorder Treatment Revenue by Application (2025-2030)
5.2.3 Global Opioid Use Disorder Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Opioid Use Disorder Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Trevena
6.1.1 Trevena Corporation Information
6.1.2 Trevena Description and Business Overview
6.1.3 Trevena Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Trevena Opioid Use Disorder Treatment Product Portfolio
6.1.5 Trevena Recent Developments/Updates
6.2 Aphios
6.2.1 Aphios Corporation Information
6.2.2 Aphios Description and Business Overview
6.2.3 Aphios Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Aphios Opioid Use Disorder Treatment Product Portfolio
6.2.5 Aphios Recent Developments/Updates
6.3 Kyowa kirin
6.3.1 Kyowa kirin Corporation Information
6.3.2 Kyowa kirin Description and Business Overview
6.3.3 Kyowa kirin Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Kyowa kirin Opioid Use Disorder Treatment Product Portfolio
6.3.5 Kyowa kirin Recent Developments/Updates
6.4 Gamida-Cell
6.4.1 Gamida-Cell Corporation Information
6.4.2 Gamida-Cell Description and Business Overview
6.4.3 Gamida-Cell Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Gamida-Cell Opioid Use Disorder Treatment Product Portfolio
6.4.5 Gamida-Cell Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Corporation Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis Opioid Use Disorder Treatment Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Titan Pharmaceutical
6.6.1 Titan Pharmaceutical Corporation Information
6.6.2 Titan Pharmaceutical Description and Business Overview
6.6.3 Titan Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Titan Pharmaceutical Opioid Use Disorder Treatment Product Portfolio
6.6.5 Titan Pharmaceutical Recent Developments/Updates
6.7 Hikma Pharmaceutical
6.6.1 Hikma Pharmaceutical Corporation Information
6.6.2 Hikma Pharmaceutical Description and Business Overview
6.6.3 Hikma Pharmaceutical Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceutical Opioid Use Disorder Treatment Product Portfolio
6.7.5 Hikma Pharmaceutical Recent Developments/Updates
6.8 MediciNova
6.8.1 MediciNova Corporation Information
6.8.2 MediciNova Description and Business Overview
6.8.3 MediciNova Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 MediciNova Opioid Use Disorder Treatment Product Portfolio
6.8.5 MediciNova Recent Developments/Updates
6.9 Alkermes
6.9.1 Alkermes Corporation Information
6.9.2 Alkermes Description and Business Overview
6.9.3 Alkermes Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Alkermes Opioid Use Disorder Treatment Product Portfolio
6.9.5 Alkermes Recent Developments/Updates
6.10 BioDelivery Sciences International
6.10.1 BioDelivery Sciences International Corporation Information
6.10.2 BioDelivery Sciences International Description and Business Overview
6.10.3 BioDelivery Sciences International Opioid Use Disorder Treatment Sales, Revenue and Gross Margin (2019-2024)
6.10.4 BioDelivery Sciences International Opioid Use Disorder Treatment Product Portfolio
6.10.5 BioDelivery Sciences International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Opioid Use Disorder Treatment Industry Chain Analysis
7.2 Opioid Use Disorder Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Opioid Use Disorder Treatment Production Mode & Process
7.4 Opioid Use Disorder Treatment Sales and Marketing
7.4.1 Opioid Use Disorder Treatment Sales Channels
7.4.2 Opioid Use Disorder Treatment Distributors
7.5 Opioid Use Disorder Treatment Customers
8 Opioid Use Disorder Treatment Market Dynamics
8.1 Opioid Use Disorder Treatment Industry Trends
8.2 Opioid Use Disorder Treatment Market Drivers
8.3 Opioid Use Disorder Treatment Market Challenges
8.4 Opioid Use Disorder Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Opioid Use Disorder Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Opioid Use Disorder Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Opioid Use Disorder Treatment Market Competitive Situation by Manufacturers in 2023
Table 4. Global Opioid Use Disorder Treatment Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Opioid Use Disorder Treatment Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Opioid Use Disorder Treatment Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Opioid Use Disorder Treatment Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Opioid Use Disorder Treatment Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Opioid Use Disorder Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Opioid Use Disorder Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Opioid Use Disorder Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Opioid Use Disorder Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Opioid Use Disorder Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder Treatment as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Opioid Use Disorder Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Opioid Use Disorder Treatment Sales by Region (2019-2024) & (K Units)
Table 18. Global Opioid Use Disorder Treatment Sales Market Share by Region (2019-2024)
Table 19. Global Opioid Use Disorder Treatment Sales by Region (2025-2030) & (K Units)
Table 20. Global Opioid Use Disorder Treatment Sales Market Share by Region (2025-2030)
Table 21. Global Opioid Use Disorder Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Opioid Use Disorder Treatment Revenue Market Share by Region (2019-2024)
Table 23. Global Opioid Use Disorder Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Opioid Use Disorder Treatment Revenue Market Share by Region (2025-2030)
Table 25. North America Opioid Use Disorder Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Opioid Use Disorder Treatment Sales by Country (2019-2024) & (K Units)
Table 27. North America Opioid Use Disorder Treatment Sales by Country (2025-2030) & (K Units)
Table 28. North America Opioid Use Disorder Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Opioid Use Disorder Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Opioid Use Disorder Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Opioid Use Disorder Treatment Sales by Country (2019-2024) & (K Units)
Table 32. Europe Opioid Use Disorder Treatment Sales by Country (2025-2030) & (K Units)
Table 33. Europe Opioid Use Disorder Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Opioid Use Disorder Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Opioid Use Disorder Treatment Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Opioid Use Disorder Treatment Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Opioid Use Disorder Treatment Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Opioid Use Disorder Treatment Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Opioid Use Disorder Treatment Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Opioid Use Disorder Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Opioid Use Disorder Treatment Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Opioid Use Disorder Treatment Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Opioid Use Disorder Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Opioid Use Disorder Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Opioid Use Disorder Treatment Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Opioid Use Disorder Treatment Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Opioid Use Disorder Treatment Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Opioid Use Disorder Treatment Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Opioid Use Disorder Treatment Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Opioid Use Disorder Treatment Sales (K Units) by Type (2019-2024)
Table 51. Global Opioid Use Disorder Treatment Sales (K Units) by Type (2025-2030)
Table 52. Global Opioid Use Disorder Treatment Sales Market Share by Type (2019-2024)
Table 53. Global Opioid Use Disorder Treatment Sales Market Share by Type (2025-2030)
Table 54. Global Opioid Use Disorder Treatment Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Opioid Use Disorder Treatment Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Opioid Use Disorder Treatment Revenue Market Share by Type (2019-2024)
Table 57. Global Opioid Use Disorder Treatment Revenue Market Share by Type (2025-2030)
Table 58. Global Opioid Use Disorder Treatment Price (US$/Unit) by Type (2019-2024)
Table 59. Global Opioid Use Disorder Treatment Price (US$/Unit) by Type (2025-2030)
Table 60. Global Opioid Use Disorder Treatment Sales (K Units) by Application (2019-2024)
Table 61. Global Opioid Use Disorder Treatment Sales (K Units) by Application (2025-2030)
Table 62. Global Opioid Use Disorder Treatment Sales Market Share by Application (2019-2024)
Table 63. Global Opioid Use Disorder Treatment Sales Market Share by Application (2025-2030)
Table 64. Global Opioid Use Disorder Treatment Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Opioid Use Disorder Treatment Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Opioid Use Disorder Treatment Revenue Market Share by Application (2019-2024)
Table 67. Global Opioid Use Disorder Treatment Revenue Market Share by Application (2025-2030)
Table 68. Global Opioid Use Disorder Treatment Price (US$/Unit) by Application (2019-2024)
Table 69. Global Opioid Use Disorder Treatment Price (US$/Unit) by Application (2025-2030)
Table 70. Trevena Corporation Information
Table 71. Trevena Description and Business Overview
Table 72. Trevena Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Trevena Opioid Use Disorder Treatment Product
Table 74. Trevena Recent Developments/Updates
Table 75. Aphios Corporation Information
Table 76. Aphios Description and Business Overview
Table 77. Aphios Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Aphios Opioid Use Disorder Treatment Product
Table 79. Aphios Recent Developments/Updates
Table 80. Kyowa kirin Corporation Information
Table 81. Kyowa kirin Description and Business Overview
Table 82. Kyowa kirin Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Kyowa kirin Opioid Use Disorder Treatment Product
Table 84. Kyowa kirin Recent Developments/Updates
Table 85. Gamida-Cell Corporation Information
Table 86. Gamida-Cell Description and Business Overview
Table 87. Gamida-Cell Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Gamida-Cell Opioid Use Disorder Treatment Product
Table 89. Gamida-Cell Recent Developments/Updates
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Novartis Opioid Use Disorder Treatment Product
Table 94. Novartis Recent Developments/Updates
Table 95. Titan Pharmaceutical Corporation Information
Table 96. Titan Pharmaceutical Description and Business Overview
Table 97. Titan Pharmaceutical Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Titan Pharmaceutical Opioid Use Disorder Treatment Product
Table 99. Titan Pharmaceutical Recent Developments/Updates
Table 100. Hikma Pharmaceutical Corporation Information
Table 101. Hikma Pharmaceutical Description and Business Overview
Table 102. Hikma Pharmaceutical Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Hikma Pharmaceutical Opioid Use Disorder Treatment Product
Table 104. Hikma Pharmaceutical Recent Developments/Updates
Table 105. MediciNova Corporation Information
Table 106. MediciNova Description and Business Overview
Table 107. MediciNova Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. MediciNova Opioid Use Disorder Treatment Product
Table 109. MediciNova Recent Developments/Updates
Table 110. Alkermes Corporation Information
Table 111. Alkermes Description and Business Overview
Table 112. Alkermes Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Alkermes Opioid Use Disorder Treatment Product
Table 114. Alkermes Recent Developments/Updates
Table 115. BioDelivery Sciences International Corporation Information
Table 116. BioDelivery Sciences International Description and Business Overview
Table 117. BioDelivery Sciences International Opioid Use Disorder Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. BioDelivery Sciences International Opioid Use Disorder Treatment Product
Table 119. BioDelivery Sciences International Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Opioid Use Disorder Treatment Distributors List
Table 123. Opioid Use Disorder Treatment Customers List
Table 124. Opioid Use Disorder Treatment Market Trends
Table 125. Opioid Use Disorder Treatment Market Drivers
Table 126. Opioid Use Disorder Treatment Market Challenges
Table 127. Opioid Use Disorder Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioid Use Disorder Treatment
Figure 2. Global Opioid Use Disorder Treatment Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Opioid Use Disorder Treatment Market Share by Type in 2023 & 2030
Figure 4. Romiplostim Product Picture
Figure 5. Omidubicel Product Picture
Figure 6. Nalmefene Product Picture
Figure 7. Others Product Picture
Figure 8. Global Opioid Use Disorder Treatment Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Opioid Use Disorder Treatment Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Drug Stores
Figure 12. Other
Figure 13. Global Opioid Use Disorder Treatment Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Opioid Use Disorder Treatment Market Size (2019-2030) & (US$ Million)
Figure 15. Global Opioid Use Disorder Treatment Sales (2019-2030) & (K Units)
Figure 16. Global Opioid Use Disorder Treatment Average Price (US$/Unit) & (2019-2030)
Figure 17. Opioid Use Disorder Treatment Report Years Considered
Figure 18. Opioid Use Disorder Treatment Sales Share by Manufacturers in 2023
Figure 19. Global Opioid Use Disorder Treatment Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Opioid Use Disorder Treatment Players: Market Share by Revenue in 2023
Figure 21. Opioid Use Disorder Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Opioid Use Disorder Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Opioid Use Disorder Treatment Sales Market Share by Country (2019-2030)
Figure 24. North America Opioid Use Disorder Treatment Revenue Market Share by Country (2019-2030)
Figure 25. United States Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Opioid Use Disorder Treatment Sales Market Share by Country (2019-2030)
Figure 28. Europe Opioid Use Disorder Treatment Revenue Market Share by Country (2019-2030)
Figure 29. Germany Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Netherlands Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Opioid Use Disorder Treatment Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Opioid Use Disorder Treatment Revenue Market Share by Region (2019-2030)
Figure 36. China Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Opioid Use Disorder Treatment Sales Market Share by Country (2019-2030)
Figure 44. Latin America Opioid Use Disorder Treatment Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Opioid Use Disorder Treatment Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Opioid Use Disorder Treatment Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Opioid Use Disorder Treatment Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Opioid Use Disorder Treatment by Type (2019-2030)
Figure 54. Global Revenue Market Share of Opioid Use Disorder Treatment by Type (2019-2030)
Figure 55. Global Opioid Use Disorder Treatment Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Opioid Use Disorder Treatment by Application (2019-2030)
Figure 57. Global Revenue Market Share of Opioid Use Disorder Treatment by Application (2019-2030)
Figure 58. Global Opioid Use Disorder Treatment Price (US$/Unit) by Application (2019-2030)
Figure 59. Opioid Use Disorder Treatment Value Chain
Figure 60. Opioid Use Disorder Treatment Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock